Evidence map›Paper›PMID 15743779›Full record

ArticleThe American journal of pathology2005

Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity.

Suzy A A Comhair, Weiling Xu, Sudakshina Ghosh, Frederik B J M Thunnissen, Alexandru Almasan, William J Calhoun, Allison J Janocha, Lemin Zheng, Stanley L Hazen, Serpil C Erzurum

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01049178 (Antioxidant Enzyme Induction as a New Approach to Therapy in Patients With Asthma), which is not on this map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01049178 phase2 / phase3withdrawnnot on this mapstarted 2010, after this paper: background citation

Antioxidant Enzyme Induction as a New Approach to Therapy in Patients With Asthma

TypeinterventionalSponsorVanderbilt UniversityRan2010 to 2010Enrolled0ConditionsAtopic AsthmaArmsOral Silymarin, Oral Silymarin, maintenance dose, Placebo
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 193 citations in OpenAlex.

  1. Trial
  2. Article
  3. Therapeutic effects ofAvicenna journal of phytomedicine · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Antigen stasis and airway nitrosative stress in human primary ciliary dyskinesia.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. PM2.5 Exposure and Asthma Development: The Key Role of Oxidative Stress.Oxidative medicine and cellular longevity · 2022
    Review
  16. Article
  17. Review
  18. Review
  19. Oxidative stress induced byRSC advances · 2021
    Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Suzy A A ComhairDepartment of Pathobiology, The Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195, USA.
Weiling Xu
Sudakshina Ghosh
Frederik B J M Thunnissen
Alexandru Almasan
William J Calhoun
Allison J Janocha
Lemin Zheng
Stanley L Hazen
Serpil C Erzurum
Cleveland Clinic · USCanisius-Wilhelmina Ziekenhuis · NLCleveland Foundation · USUniversity of Pittsburgh · US

Funding

Structural Determinants Of Ceruloplasmin Inflammatory ActivityP01HL076491 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN · 2004 to 2019
$27.3M
VIRALLY-INDUCED STAT-1, STAT-3 AND STAT-6M01RR018390 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI SIEDLECKI, SANDRA LEE · 2003 to 2007
$11.0M
Peroxidases and AsthmaR01HL061878 · NHLBI · CLEVELAND CLINIC LERNER COL/MED-CWRU · PI HAZEN, STANLEY L · 1998 to 2005
$1.7M
NO SYNTHESIS AND CONSUMPTION IN THE LUNGK24HL004265 · NHLBI · CLEVELAND CLINIC LERNER COL/MED-CWRU · PI ERZURUM, SERPIL C. · 2000 to 2004
$510k
NCRR NIH HHS M01 RR018390NCRR NIH HHS N01 RR018390NHLBI NIH HHS HL 04265NHLBI NIH HHS HL076491NHLBI NIH HHS HL 61878NHLBI NIH HHS P01 HL076491NHLBI NIH HHS R01 HL061878NIAID NIH HHS AI 70640
6 · The paper itself

Abstract

Airway hyperresponsiveness and remodeling are defining features of asthma. We hypothesized that impaired superoxide dismutase (SOD) antioxidant defense is a primary event in the pathophysiology of hyperresponsiveness and remodeling that induces apoptosis and shedding of airway epithelial cells. Mechanisms leading to apoptosis were studied in vivo and in vitro. Asthmatic lungs had increased apoptotic epithelial cells compared to controls as determined by terminal dUTP nick-end labeling-positive cells. Apoptosis was confirmed by the finding that caspase-9 and -3 and poly (ADP-ribose) polymerase were cleaved. On the basis that SOD inactivation triggers cell death and low SOD levels occur in asthma, we tested whether SOD inactivation plays a role in airway epithelial cell death. SOD inhibition increased cell death and cleavage/activation of caspases in bronchial epithelial cells in vitro. Furthermore, oxidation and nitration of MnSOD were identified in the asthmatic airway, correlating with physiological parameters of asthma severity. These findings link oxidative and nitrative stress to loss of SOD activity and downstream events that typify asthma, including apoptosis and shedding of the airway epithelium and hyperresponsiveness.

Indexed as

AntioxidantsApoptosisAsthmaBlotting, NorthernBlotting, WesternBronchiBronchoscopyCaspase 3Caspase 9CaspasesCell DeathCell LineCell ProliferationCell SurvivalDNAElectrophoresis, Gel, Two-DimensionalAntioxidantsCASP3 protein, humanCASP9 protein, humanCaspase 3Caspase 9CaspasesDNAKi-67 AntigenNitrogenOxygenPoly(ADP-ribose) PolymerasesRNA, Small InterferingSuperoxide Dismutase

Identifiers

PMID15743779
PMCPMC1602353
OpenAlexW2124542794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.